Masonic Cancer Center, University of Minnesota
| Date | Presenter |
| September 22, 2003 Transplant therapy for Multiple Myeloma: Data Update and New Protocols | Mukta Arora, M.D. Hematology, Oncology and Transplantation Division Department of Medicine University of Minnesota |
| September 29, 2003 Mycophenolate Exposure in Nonmyeloablative HSCT: Is It Relevant to Engraftment and Acute GVHD? | Pamala Jacobson, Pharm. D. Assistant Professor Experimental & Clinical Pharmacology College of Pharmacy University of Minnesota |
| October 6, 2003 | Attending meeting |
| October 13, 2003 Long Term Complications in Survivors after Stem Cell Transplant Part 1:
Reproductive Impairments in Survivors of Stem Cell Transplant Gonadal Failure After BMT Male Sexual Function Following BMT |
K. Scott Baker, M.D., M.S. Assistant Professor Department of Pediatrics
Anna Petryk, M.D. Assistant Professor Department of Pediatrics Bruce Redmon, M.D. Associate Professor Departments of Medicine and Urologic Surgery |
| October 20, 2003 Cancelled | Cancelled |
| October 27, 2003 Tracking the Fate and Function of Tumor-Specific T Cells During Immune Reconstitution | Hyam Levitsky, M.D. Professor of Oncology, Medicine, and Urology Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School of Medicine Hosted by: Bruce Blazar, MD |
November 3, 2003 |
CANCELED |
November 10, 2003 Novel Methods to Prevent GVHD |
Nelson J. Chao, MD Professor of Medicine and Immunology Director, BMT Program Duke University Hosted by: Bruce Blazar, M.D. Sponsored by AMGEN |
November 17, 2003 Mechanisms and Molecules in the Graft vs. Leukemia Response |
Stanley Riddell, M.D. Member, Program in Immunology Fred Hutchinson Cancer Research Center Professor of Medicine University of Washington Hosted by: Bruce Blazar, MD |
November 24, 2003 Transplant for AML: What Are We Doing and Why? |
Paul Orchard, M.D. Assistant Professor Department of Pediatrics |
December 1, 2003 ASH Practice |
K. Scott Baker , MD , MS : “Late Effects In Survivors Of Related Or Unrelated Donor BMT For CML” Ashish R. Kumar, MD, PhD : “ Hoxa9 Influences The Phenotype But Not The Incidence of Mll -fusion Gene Leukemia” Jeffrey S. Miller, MD : “Adoptive Immunotherapy of Cancer Using Haploidentical Natural Killer (NK) Cell Infusions To Overcome Inhibitory Receptor Recognition of Class 1 Molecules” |
December 8, 2003 No conference due to ASH |
|
December 15, 2003 Adoptive Transfer of Ex Vivo CD3/CD28 Stimulated T Cells for ImmuneAugmentation |
Bruce Levine, M.D. Director, Clinical Cell and Vaccine Production Facility Abramson Cancer Center University of Pennsylvania Hosted by: Jeff Miller. M.D.
|
December 22, 2003 Canceled due to holidays |
|
December 29, 2003 Canceled due to holidays |
|
January 5, 2004 |
Catherine Verfaillie, M.D. Professor, Department of Medicine Director, Stem Cell Institute University of Minnesota |
January 12, 2004 Long Term Complications in Survivors after Stem Cell Transplant Part 2:
|
Edward Cheng, M.D. Professor Orthopaedic Surgery University of MinnesotaAvascular Necrosis Linda Burns, M.D. Associate Professor Department of Medicine University of MinnesotaOsteoporosis Study |
| January 19, 2004 | MLK Holiday-BMT Conference Canceled |
January 26, 2004 Polyomavirus Infections Including Cystitis in HSCT Recipients |
Jo-Anne van Burik, M.D. Assistant Professor of Medicine, Division of Infectious Diseases & International Medicine University of Minnesota |
| February 2, 2004 | Attending Meeting |
February 9, 2004 A new Phase 1 Protocol: Infusion of CD4+ CD25+ Suppressor Cells for GVHD Prevention |
Margaret MacMillan, M.D. Assistant Professor, Department of Pediatrics, University of Minnesota
Wayne Godfrey, M.D. Assistant Professor, Departments of Pediatrics and Medicine, University of Minnesota |
| February 16, 2004 | Canceled due to tandem meetings |
February 23, 2004 Lung injury and repair post-BMT |
Angela Panoskaltsis-Mortari, Ph.D., D (ABMLI), Assistant Professor, Department of Pediatrics, Hematology/Oncology And Blood and Marrow Transplantation, Pulmonary and Critical Care Medicine, University of Minnesota |
March 1, 2004 Palliative care in a quaternary hospital |
Mark Leenay, M.D. Medical Director Transition and Life Choices Fairview University Medical Clinic |
March 8, 2004 Alternatives to methotrexate in GVHD prophylaxis |
Joseph H. Antin, M.D. Chief, Stem Cell Transplant Program Professor of Medicine Dana-Farber Cancer Institute Harvard Medical School Sponsor: Fujisawa Healthcar Host: Daniel Weisdorf |
March 15, 2004 Stem Cell Transplantation for Lymphoma: Who Benefits? |
Robert M. Dean, M.D. Clinical Fellow, Medical Oncology Clinical Research Unit Center for Cancer Research, National Cancer Institute Bethesda, MD |
March 22, 2004 New Myeloma Protocols |
Mukta Arora, M.D. Hematology, Oncology and Transplantation Division Department of Medicine University of Minnesota |
| March 29, 2004 | Cancelled due to Cancer Center function in 450 CCRB |
April 5, 2004 New ID Guidelines and What to do with Galactomannan Assays |
Jo-Anne van Burik, M.D. Assistant Professor of Medicine, Division of Infectious Diseases & International Medicine, University of Minnesota |
April 12, 2004 Update on UCB Transplantation in Adults |
Juliet Barker, MBBS (Hons), FRACP Assistant Professor of Medicine Division of Hematology, Oncology and Transplantation Blood and Marrow Transplant Program |
April 19, 2004 Clinical Implications of Platelet Dosing Strategies: A new Clinical Trial |
Jeffrey McCullough, M.D. Professor, Department of Laboratory Medicine & Pathology American Red Cross Chair, Transfusion Medicine Director, Biomedical Engineering Institute |
April 26, 2004 Immunopathology of Graft Versus Host Disease |
Robert Korngold, Ph.D. Professor Kimmel Cancer Center Jefferson Medical College Philadelphia, PA Hosted by: Bruce Blazar, M.D. |
May 3, 2004 Outcome of BMT for Large Cell Lymphoma |
Linda Burns, M.D. Associate Professor Medicine Division of HOT University of Minnesota -and- Rachel Lerner, M.D. Hematology, Oncology and Transplantation Division Department of Medicine University of Minnesota |
May 10, 2004 BMT Program Meeting |
|
May 17, 2004 Strategies to Augment Anti-tumor Immunity in Autologous Stem Cell Transplantation |
Ivan Barrello, M.D. Assistant Professor of Oncology Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hosted by: Bruce Blazar, M.D. |
May 24, 2004 Outcome of Ethnic Minorities with Acute or Chronic Leukemia Treated with Hematopoietic Stem Cell Transplantation in the United States |
K. Scott Baker, MD, MS Assistant Professor Pediatric Blood and Marrow Transplant Program University of Minnesota |
| May 31, 2004 | Canceled - Memorial Day Holiday |
June 7, 2004 HHV-6 Infections: which HSCT patients should be monitored |
JoAnne van Burik, M.D. Assistant Professor of Medicine, Division of Infectious Diseases & International Medicine University of Minnesota |